Going to be a tough job fixing the mess our prior CEO created. While a lot of that exec team is gone now the new guy needs to rip out the old rot that persists there with people like Andrew H. That ass clown is so delusional that he thinks he is the chosen one and the solution to the problem when in fact he IS THE PROBLEM. Tenure isnt the solution AH, its talent and you come up empty there. You have decimated a direct sales team that was purchased for you and handed over on a silver platter. You have assembled a team of managers below you who are every bit as empty as you are and we won't work for them or YOU. Hey Anthony B! Keep ripping out the old rot or the house eventually falls. Don't let the empty suits you have in "Leadership" run off the remaining few good people we have. Just flush the toilet and rebuild.
When Q3 ASP hits and BV asp tanks again by double digits the stick is going to tumble and all decent size accounts will bail unless sakes management drops their pants which will fuel the decrease in ASP. Do you notice other companies are not dropping their price to beg to keep accounts. They have long term vision. We do not it’s all just trying to stay alive.
Listening to the investor call was a yawn this week too. Our new CEO has "confidence" in his direct reporting commercial leaders. Need to let that soak in. We had three. PS (got pushed out) so they moved the weaker international manager AD into that slot leaving international open. AH is still playing house of cards in his role with our surgical group. If those two give you confidence in your commercial leadership abilities then I have some old Theranos shares to sell you. Paying upwards of 50% commissions to distributors to sell our magikal allograf is not sustainable but looks similar in approach to our HA shuffle as stated above. Pinstripes on a Kia doesnt make it a Porsche. Time to get some proven commercial people in place to fix the root issues.
Listened yesterday to a ML health tech analyst and a call in question came regarding BV. He discussed the past 4 leaders, the expansion errors and successes. The 100 million gift given by walking away from a purchase was explained, and finally the buy/sell strategy. He said all the easy money has been made ( those who purchased at the .80 per share low. ). He stated the company will drop again in value and WHEN it drops below $2.00 per share, he will consider changing his opinion. He still feels that BV shouldn’t be a part of one’s portfolio.
